Loading...

Warby Parker Inc.

WRBYNYSE
Healthcare
Medical - Instruments & Supplies
$27.02
$0.95(3.64%)

Warby Parker Inc. (WRBY) Financial Performance & Income Statement Overview

Access detailed quarterly and annual financial reports for Warby Parker Inc. (WRBY), covering cash flow, earnings, and balance sheets.

Revenue Growth
15.16%
15.16%
Operating Income Growth
58.18%
58.18%
Net Income Growth
67.74%
67.74%
Operating Cash Flow Growth
61.90%
61.90%
Operating Margin
-2.20%
2.20%
Gross Margin
54.49%
54.49%
Net Profit Margin
-1.12%
1.12%
ROE
-2.65%
2.65%
ROIC
-3.19%
3.19%

Warby Parker Inc. (WRBY) Income Statement & Financial Overview

Access detailed annual and quarterly income data for Warby Parker Inc. WRBY financial performance.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$223.78M$190.64M$192.45M$188.22M
Cost of Revenue$97.80M$87.52M$87.58M$86.59M
Gross Profit$125.98M$103.13M$104.87M$101.64M
Gross Profit Ratio$0.56$0.54$0.54$0.54
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$120.04M$112.54M$111.48M$110.59M
Operating Expenses$123.51M$112.54M$111.48M$110.59M
Total Costs & Expenses$221.31M$200.06M$199.06M$197.18M
Interest Income$2.46M$0.00$0.00$0.00
Interest Expense$0.00$0.00$0.00$0.00
Depreciation & Amortization$12.16M$12.33M$0.00$11.12M
EBITDA$14.63M$2.92M-$6.61M$2.17M
EBITDA Ratio$0.07$0.02-$0.03$0.01
Operating Income$2.47M-$9.42M-$6.61M-$8.96M
Operating Income Ratio$0.01-$0.05-$0.03-$0.05
Other Income/Expenses (Net)$2.46M$2.63M$2.84M$2.57M
Income Before Tax$4.93M-$6.78M-$3.77M-$6.39M
Income Before Tax Ratio$0.02-$0.04-$0.02-$0.03
Income Tax Expense$1.45M$93000.00$301000.00$373000.00
Net Income$3.47M-$6.88M-$4.07M-$6.76M
Net Income Ratio$0.02-$0.04-$0.02-$0.04
EPS$0.03-$0.06-$0.03-$0.06
Diluted EPS$0.03-$0.06-$0.03-$0.06
Weighted Avg Shares Outstanding$121.95M$121.41M$120.89M$120.09M
Weighted Avg Shares Outstanding (Diluted)$124.63M$121.41M$120.89M$120.09M

Financial performance has remained strong, with revenue growing from $188.22M in Q2 2024 to $223.78M in Q1 2025. Gross profit continued to perform well, with margins at 56% in the latest quarter. Operating income reached $2.47M in Q1 2025, holding a steady 1% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $14.63M. Net income rose to $3.47M, keeping EPS at $0.03. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;